Slide 1

What if the most common cell in the body could treat or cure some of the most common chronic diseases?

Slide 2

Latest News

FibroBiologics Appoints Mark C. Andersen as Chief Financial Officer
Slide 3

J.P. Morgan 2023

Connect with FibroBiologics in San Francisco January 9-12, 2023.

News

Publications

Pipeline

harnessing the power of fibroblasts

What are Fibroblasts?

There are only two cell types in the human body that can regenerate tissue and organs: stem cells and fibroblasts. Fibroblasts comprise the main cell type of connective tissue, possessing a spindle-shaped morphology, and produce and maintain the extracellular matrix responsible for the structural integrity of tissues and organs.

1

CNS Disorders
(Multiple Sclerosis)
The results of our pre-clinical and safety-centered limited clinical trial data to treat and cure autoimmune diseases are promising. Read more

2

Thymus
As we age, key organs in the body like the thymus decline. We are currently exploring the potential capabilities of fibroblasts to improve and extend the productive life of the thymus through fibroblast cell-based therapies. Read more

3

Spleen
As we age, key organs in the body like the spleen decline. We are currently exploring the potential capabilities of fibroblasts to improve and extend the productive life of the spleen. Read more

4

Skin (wound healing)
Fibroblasts naturally play an integral part of the complex and intricately orchestrated wound healing process that involves multiple systems and cells. Read more

fibroblast cell-based therapies

Why use Fibroblasts?

Our studies have proven fibroblasts to be more effective and more potent than stem cells in regeneration and immune modulation. As the most common cell in the human body, fibroblasts are easier to source, culture, and differentiate into many different cell types.

Backed by Science.
Informed by Experts.

Our distinguished research and scientific boards are led by the industry’s top experts and key opinion leaders. Together, they bring years of experience to FibroBiologics that help shape strategy, guide the development of our products and our pipeline, and position our company for success.

“Our science must be better. It must be irrefutable, impeccable and repeatable.”

–Pete O’Heeron, FibroBiologics, Chairman/Founder/CEO

Patents & IP

Inquiry

Contact us for intellectual property updates, events and more:

FOR SCIENTISTS ONLY: New articles added frequently.
+